Pembrolizumab combo before/after surgery and radiation significantly improved event-free survival in resectable advanced head ...

Low-dose computed tomography is more sensitive than chest radiography in detecting lung metastases or second primary lung cancer in patients with HNSCC.

Reducing the dose of radiation to nodal regions is safe and does not impact the risk of recurrence in patients with head and neck cancer, a study suggests.

COVID-19 vaccine program progressing with additional data evaluating GEO-CM04S1 as booster to mRNA vaccines in healthy adults expected in second quarter of 2025  Clinical evaluation of GEO-MVA, ...

The American Association for Cancer Research’s annual conference featured updates from several companies on key candidates ...

He is a specialist in head and neck cancer and in melanoma, and a Fellow of the Royal College of Physicians and the Royal College of Radiologists.

Head and neck cancer is the sixth most common cancer in the world, with almost two-thirds of patients diagnosed when they have locally advanced disease. NHS England has started a pilot trial of an ...

While immunotherapies have transformed treatment of many types of cancer, they do sometimes fail to have an impact – as Merck & Co has just observed in a study of Keytruda in head and neck cancer.

Cancer is a debilitating illness that remains a persistent threat to humanity and is one of the leading causes of death globally. It is imperative to recognize the prevalence of head and neck ...

May 1, 2025GeoVax Labs, Inc. beats earnings expectations. Reported EPS is $-0.45, expectations were $-0.59. Operator: Good afternoon. And welcome everyone to the GeoVax First Quarter 2025 Corporate ...

With bipartisan momentum toward re-shoring essential health infrastructure, GeoVax stands ready to partner with HHS, BARDA, and other federal agencies to fulfill the Executive Order’s vision of a self ...